Seegene, Inc. (KOSDAQ:096530)
 25,300
 -50 (-0.20%)
  Oct 31, 2025, 3:30 PM KST
Seegene Market Cap
Seegene has a market cap or net worth of 1.17 trillion as of October 30, 2025. Its market cap has increased by 2.20% in one year.
Market Cap 
 1.17T
Enterprise Value 
 766.36B
Revenue 
 454.22B
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
25,300.00
Market Cap Chart
Since September 10, 2010, Seegene's market cap has increased from 194.31B to 1.17T, an increase of 501.59%. That is a compound annual growth rate of 12.58%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 1.17T | 11.35% | 
| Dec 30, 2024 | 1.05T | -1.30% | 
| Dec 28, 2023 | 1.06T | -22.46% | 
| Dec 29, 2022 | 1.37T | -56.39% | 
| Dec 30, 2021 | 3.15T | -37.30% | 
| Dec 30, 2020 | 5.02T | 529.69% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 86.90T | 
| Celltrion | 38.90T | 
| ALTEOGEN | 24.95T | 
| SK Biopharmaceuticals | 8.97T | 
| Yuhan | 8.77T | 
| HLB Co., Ltd. | 6.30T | 
| Peptron | 6.18T | 
| PharmaResearch | 5.36T |